raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:3152

Sclerosteosis

Synonyms: Cortical hyperostosis-syndactyly syndrome

Type
Malformation syndrome
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Childhood, Neonatal
Status
active

Sclerosteosis is a very rare serious sclerosing hyperostosis syndrome characterized clinically by variable syndactyly and progressive skeletal overgrowth (particularly of the skull), resulting in distinctive facial features (mandibular overgrowth, frontal bossing, midfacial hypoplasia), cranial nerve entrapment causing facial palsy and deafness, and potentially lethal elevation of intracranial pressure.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enSclerosteosisCortical hyperostosis-syndactyly syndrome
frSclérostéoseSyndrome d'hyperostose corticale-syndactylie
deSklerosteoseHyperostosis corticalis mit Syndaktylie
esEsclerosteosisHiperostosis cortical sindactilia
itSclerosteosiIperostosi corticale - sindattilia
nlSclerosteoseCorticale hyperostose - syndactylie-syndroom
ptEsclerosteoseSíndrome de hiperostose cortical-sindactilia
plSklerosteozaHiperostoza korowa - syndaktylia
csSklerosteózaSyndrom zahrnující kortikální hyperostózu a syndaktylii
ukСклеростеозСиндром кортикального гіперостозу-синдактилії
zh硬化性狭窄骨皮质增生-并指(趾)综合征
trSklerosteozKortikal hiperostoz-sindaktili sendrom

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM269500BTNTvalidated
OMIM614305BTNTvalidated
ICD-10M85.2NTBTattributedvalidated
ICD-11LD24.1YNTBTindexvalidated
MONDO0017838Evalidated
MeSHC537525Evalidated
UMLSC0265301Evalidated
GARD4771Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

2 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
SOSTDisease-causing germline mutation(s) (loss of function) inAssessedHGNC:13771ENSG0000016794160574017q21.31sclerostin20301406[PMID]
LRP4Disease-causing germline mutation(s) inAssessedHGNC:6696ENSG0000013456960427011p11.2LDL receptor related protein 421471202[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families80 casesWorldwideCase(s)Validated20301406[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_20301406[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

14 annotations · validated 2016-06-01
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:00012332-3 finger syndactyly
HP:0003103Abnormal cortical bone morphology
HP:0000366Abnormality of the nose
HP:0004493Craniofacial hyperostosis
HP:0009838Curved distal phalanges of the hand
HP:0005019Diaphyseal thickening
HP:0006101Finger syndactyly
HP:0100798Fingernail dysplasia
HP:0011001Increased bone mineral density
HP:0000098Tall stature
Frequent (79-30%)
HP:0010628Facial palsy
HP:0000508Ptosis
HP:0000407Sensorineural hearing impairment
Occasional (29-5%)
HP:0000648Optic atrophy

Run the differential on the 10 obligate / very frequent terms

7

Sources for this card